<H1>Tasigna </H1><P>Tasigna (nilotinib) is a cancer treatment for Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic or accelerated phase in patients resistant to, or experiencing significant toxicity during cancer treatment with, imatinib.</P>